QA Audit Procedure [GxP / QC / QA]

posted by swapnil.kuche – 2011-01-20 07:47 (4844 d 02:11 ago) – Posting: # 6452
Views: 23,649

(edited by swapnil.kuche on 2011-01-20 11:20)

Dear All,

Most of Quality Assurance departments used to claim that 20% raw data (Inprocess & Retrospective) and final bioequivalence report will be audited during course of conduct of the study.
My question is
  1. Do you feel it's ideal procedure to be followed?
  2. If yes. Do you have any reference regulatory guidance or any literature for the same supporting above mentioned statement?
    :ponder:
Thanks
Swapnil

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,655 registered users;
119 visitors (1 registered, 118 guests [including 5 identified bots]).
Forum time: 10:58 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5